LEGAL ACTION AGAINST API
Australian Pharmaceutical Industries (ASX:API) today confirmed that a class action has
been filed against it in Victoria’s Supreme Court. API denies the plaintiffs’ allegations and
will vigorously defend the action.
API said that it remains focused on supporting Priceline Pharmacy franchisees through
these difficult COVID-19 times, so that they can fully play their role in the distribution of vital
medicines and the COVID-19 vaccine and serve their communities during and beyond the
Given the matters alleged by the plaintiffs are now before a Court, it would be
inappropriate for API to comment further.
Announcement authorised by the CEO & Managing Director of API.
i hold API